A - Human Necessities – 23 – L
Patent
A - Human Necessities
23
L
A23L 1/29 (2006.01) A23L 1/305 (2006.01)
Patent
CA 2593033
A method of continuously reducing the circulating level of insulin like growth factor 1 (IGF-1) in the first few months of the life of an infant comprises administering to the 5 infant a nutritional composition comprising proteins in an amount such that the composit ion contains less than 2.25g of protein per 100kcal. As IGF-1 is known to be a key control point in nutritional regulation of growth, this may offer a method of reducing the risk of developing obesity in later life.
L~invention concerne un procédé permettant de réduire en continu le niveau de circulation d~un facteur de croissance 1 de type insuline (IGF-1) au cours des premiers mois de la vie d~un nourrisson comprenant l~administration au nourrisson (5) d~une composition nutritionnelle contenant des protéines en une quantité telle que la composition contienne moins de 2,25 g de protéines par 100 kcal. Etant donné que l~IGF-1 est connu pour constituer un point de contrôle clé dans la régulation nutritionnelle de la croissance, le présent procédé peut permettre de réduire le risque pour le nourrisson de développer une obésité au cours de sa vie future.
Borden Ladner Gervais Llp
Nestec S.a.
LandOfFree
Use of infant formula with reduced protein content does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of infant formula with reduced protein content, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of infant formula with reduced protein content will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1703057